Skip to main content

MRI in Inflammatory Bowel Disease

  • Chapter
  • First Online:
Crohn's Disease and Ulcerative Colitis

Abstract

MR enterography is increasingly being recognized as an imaging gold standard in the detection and staging of patients with inflammatory bowel disease. Its biggest advantage as compared with CT enterography is the absence of ionizing radiation. This is vital in this patient group who may go on to have multiple imaging evaluations during the course of their disease and has prompted increasing MRI referrals in an era where radiation sequelae are in the forefront of public consciousness. Moreover its non-invasive nature, high contrast resolution, multi-planar capability and lack of requirement for iodinated contrast media to provide high quality and reproducible imaging of the small bowel confer a distinct advantage over other modalities that are used to evaluate the bowel. Moreover its ability to provide functional information by utilization of MR motility sequences and diffusion weighted imaging (DWI) are unique.

There has been much work on assessing disease activity on MRI and using it as a tool to guide patient management.

This review will focus on the benefits and disadvantages of MR enterography and provide specific examples of protocols that may be used to assess the small and large bowel. These protocols will need to be tailored to address the clinical areas of concern. The benefits and limitation of differing categories of oral contrast media will also be discussed in some detail, as will characteristic imaging findings in patients with IBD involving both the large and small bowel.

An overall review of the performance characteristics as compared with conventional imaging and endoscopic techniques will be provided. The utility of MR scoring systems as an objective method for quantification of disease activity will be discussed as will the potential impact of DWI in disease evaluation in this patient population.

In the challenging area of perianal disease MRI remains an established gold standard in providing a baseline for depiction of the presence and anatomical extent of disease. It is vital therefore not only in initial management but guiding subsequent therapeutic decision-making particularly in the utilization of immune modulating drugs. The imaging technique, efficacy, classification system and the potential complications of long standing perianal disease will be described.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 249.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Loftus CG, Loftus Jr EV, Harmsen WS, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis. 2007;13(3):254–61. doi:10.1002/ibd.20029.

    Article  PubMed  Google Scholar 

  2. Brenner DJ. Medical imaging in the 21st century – getting the best bang for the rad. N Engl J Med. 2010;362(10):943–5. doi:362/10/943 [pii] 10.1056/NEJMe1000802.

    Article  PubMed  CAS  Google Scholar 

  3. Peloquin JM, Pardi DS, Sandborn WJ, et al. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2008;103(8):2015–22. doi:AJG1920 [pii] 10.1111/j.1572-0241.2008.01920.x.

    Article  PubMed  Google Scholar 

  4. Desmond AN, O’Regan K, Curran C, et al. Crohn’s disease: factors associated with exposure to high levels of diagnostic radiation. Gut. 2008;57(11):1524–9. doi:gut.2008.151415 [pii] 10.1136/gut.2008.151415.

    Article  PubMed  CAS  Google Scholar 

  5. Negaard A, Paulsen V, Sandvik L, et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn’s disease, the oral contrast method and MR enteroclysis. Eur Radiol. 2007;17(9):2294–301. doi:10.1007/s00330-007-0648-4.

    Article  PubMed  Google Scholar 

  6. Masselli G, Casciani E, Polettini E, Gualdi G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn’s disease. Eur Radiol. 2008;18(3):438–47. doi:10.1007/s00330-007-0763-2.

    Article  PubMed  Google Scholar 

  7. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008;247(1):64–79. doi:247/1/64 [pii] 10.1148/radiol.2471070611.

    Article  PubMed  Google Scholar 

  8. Schreyer AG, Geissler A, Albrich H, et al. Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn’s disease. Clin Gastroenterol Hepatol. 2004;2(6):491–7. doi:S1542356504001685 [pii].

    Article  PubMed  Google Scholar 

  9. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn’s disease. AJR Am J Roentgenol. 2009;193(1):113–21. doi:193/1/113 [pii] 10.2214/AJR.08.2027.

    Article  PubMed  Google Scholar 

  10. Albert JG, Martiny F, Krummenerl A, et al. Diagnosis of small bowel Crohn’s disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis. Gut. 2005;54(12):1721–7. doi:gut.2005.069427 [pii] 10.1136/gut.2005.069427.

    Article  PubMed  CAS  Google Scholar 

  11. Sinha R, Rajiah P, Murphy P, Hawker P, Sanders S. Utility of high-resolution MR imaging in demonstrating transmural pathologic changes in Crohn disease. Radiographics. 2009;29(6):1847–67. doi:29/6/1847 [pii] 10.1148/rg.296095503.

    Article  PubMed  Google Scholar 

  12. Sempere GA, Martinez Sanjuan V, Medina Chulia E, et al. MRI evaluation of inflammatory activity in Crohn’s disease. AJR Am J Roentgenol. 2005;184(6):1829–35. doi:184/6/1829 [pii].

    PubMed  Google Scholar 

  13. Masselli G, Brizi GM, Parrella A, Minordi LM, Vecchioli A, Marano P. Crohn disease: magnetic resonance enteroclysis. Abdom Imaging. 2004;29(3):326–34. doi:10.1007/s00261-003-0116-9.

    Article  PubMed  CAS  Google Scholar 

  14. Punwani S, Rodriguez-Justo M, Bainbridge A, et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology. 2009;252(3):712–20. doi:radiol.2523082167 [pii] 10.1148/radiol.2523082167.

    Article  PubMed  Google Scholar 

  15. Miao YM, Koh DM, Amin Z, et al. Ultrasound and magnetic resonance imaging assessmentof active bowel segments in Crohn’s disease. Clin Radiol. 2002;57(10):913–8. doi:S0009926002910597 [pii].

    Article  PubMed  CAS  Google Scholar 

  16. Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology. 2006;238(2):517–30. doi:2381040244 [pii] 10.1148/radiol.2381040244.

    Article  PubMed  Google Scholar 

  17. Rieber A, Aschoff A, Nussle K, et al. MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol. 2000;10(9):1377–82.

    Article  PubMed  CAS  Google Scholar 

  18. Madsen SM, Thomsen HS, Schlichting P, Dorph S, Munkholm P. Evaluation of treatment response in active Crohn’s disease by low-field magnetic resonance imaging. Abdom Imaging. 1999;24(3):232–9.

    Article  PubMed  CAS  Google Scholar 

  19. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Papamastorakis G, Prassopoulos P, Roussomoustakaki M. Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol. 2004;14(6):1017–24. doi:10.1007/s00330-004-2302-8.

    Article  PubMed  Google Scholar 

  20. Girometti R, Zuiani C, Toso F, et al. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn’s disease of the terminal ileum. Acad Radiol. 2008;15(2):153–64. doi:S1076-6332(07)00509-0 [pii] 10.1016/j.acra.2007.08.010.

    Article  PubMed  Google Scholar 

  21. Negaard A, Sandvik L, Berstad AE, et al. MRI of the small bowel with oral contrast or nasojejunal intubation in Crohn’s disease: randomized comparison of patient acceptance. Scand J Gastroenterol. 2008;43(1):44–51. doi:788782908 [pii] 10.1080/00365520701494813.

    Article  PubMed  Google Scholar 

  22. Siddiki H, Fidler J. MR imaging of the small bowel in Crohn’s disease. Eur J Radiol. 2009;69(3):409–17. doi:S0720-048X(08)00636-0 [pii] 10.1016/j.ejrad.2008.11.013.

    Article  PubMed  Google Scholar 

  23. Florie J, Wasser MN, Arts-Cieslik K, Akkerman EM, Siersema PD, Stoker J. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn’s disease. AJR Am J Roentgenol. 2006;186(5):1384–92. doi:186/5/1384 [pii] 10.2214/AJR.04.1454.

    Article  PubMed  Google Scholar 

  24. Froehlich JM, Waldherr C, Stoupis C, Erturk SM, Patak MA. MR motility imaging in Crohn’s disease improves lesion detection compared with standard MR imaging. Eur Radiol. 2010;20(8):1945–51. doi:10.1007/s00330-010-1759-x.

    Article  PubMed  Google Scholar 

  25. Ajaj W, Lauenstein TC, Pelster G, et al. MR colonography in patients with incomplete conventional colonoscopy. Radiology. 2005;234(2):452–9. doi:2342032001 [pii] 10.1148/radiol.2342032001.

    Article  PubMed  Google Scholar 

  26. Ajaj WM, Lauenstein TC, Pelster G, et al. Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity. Gut. 2005;54(2):257–63. doi:54/2/257 [pii] 10.1136/gut.2003.037085.

    Article  PubMed  CAS  Google Scholar 

  27. Langhorst J, Kuhle CA, Ajaj W, et al. MR colonography without bowel purgation for the assessment of inflammatory bowel diseases: diagnostic accuracy and patient acceptance. Inflamm Bowel Dis. 2007;13(8):1001–8. doi:10.1002/ibd.20140.

    Article  PubMed  Google Scholar 

  28. Gore RM, Balthazar EJ, Ghahremani GG, Miller FH. CT features of ulcerative colitis and Crohn’s disease. AJR Am J Roentgenol. 1996;167(1):3–15.

    PubMed  CAS  Google Scholar 

  29. Gore RM. Colonic contour changes in chronic ulcerative colitis: reappraisal of some old concepts. AJR Am J Roentgenol. 1992;158(1):59–61.

    PubMed  CAS  Google Scholar 

  30. Riddell R. Pathology of idiopathic inflammatory bowel disease. In: Kirsner J, editor. Inflammatory bowel disease. WB Saunders: Philadelphia, PA; 2000. p. 427–47.

    Google Scholar 

  31. Rottgen R, Herzog H, Lopez-Haninnen E, Felix R. Bowel wall enhancement in magnetic resonance colonography for assessing activity in Crohn’s disease. Clin Imaging. 2006;30(1):27–31. doi:S0899-7071(05)00174-9 [pii] 10.1016/j.clinimag.2005.07.031.

    Article  PubMed  Google Scholar 

  32. Ajaj W, Goyen M, Langhorst J, Ruehm SG, Gerken G, Lauenstein TC. MR colonography for the assessment of colonic anastomoses. J Magn Reson Imaging. 2006;24(1):101–7. doi:10.1002/jmri.20606.

    Article  PubMed  Google Scholar 

  33. Stuckle CA, Maleszka A, Kosta P, Kirchner JK, Liermann D, Adamietz IA. Computerized tomography evaluation of local recurrence of operated and adjuvant radiation treated rectal carcinoma. Normal and pathological changes after operation and irradiation of rectal carcinoma in 956 CT examinations. Radiologe. 2001;41(6):491–6.

    Article  PubMed  CAS  Google Scholar 

  34. Sailer J, Peloschek P, Reinisch W, Vogelsang H, Turetschek K, Schima W. Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol. 2008;18(11):2512–21. doi:10.1007/s00330-008-1034-6.

    Article  PubMed  Google Scholar 

  35. Oussalah A, Laurent V, Bruot O, et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut. 2010;59(8):1056–65. doi:gut.2009.197665 [pii] 10.1136/gut.2009.197665.

    Article  PubMed  Google Scholar 

  36. Spencer JA, Ward J, Beckingham IJ, Adams C, Ambrose NS. Dynamic contrast-enhanced MR imaging of perianal fistulas. AJR Am J Roentgenol. 1996;167(3):735–41.

    PubMed  CAS  Google Scholar 

  37. Horsthuis K, Lavini C, Bipat S, Stokkers PC, Stoker J. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology. 2009;251(2):380–7. doi:251/2/380 [pii] 10.1148/radiol.2512072128.

    Article  PubMed  Google Scholar 

  38. Ng SC, Plamondon S, Gupta A, et al. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn’s perineal fistulas. Am J Gastroenterol. 2009;104(12):2973–86. doi:ajg2009509 [pii] 10.1038/ajg.2009.509.

    Article  PubMed  CAS  Google Scholar 

  39. Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology. 2001;121(5):1064–72. doi:S0016508501362248 [pii].

    Article  PubMed  CAS  Google Scholar 

  40. Beets-Tan RG, Beets GL, van der Hoop AG, et al. Preoperative MR imaging of anal fistulas: does it really help the surgeon? Radiology. 2001;218(1):75–84.

    PubMed  CAS  Google Scholar 

  41. Ardizzone S, Maconi G, Cassinotti A, Massari A, Porro GB. Imaging of perianal Crohn’s disease. Dig Liver Dis. 2007;39(10):970–8. doi:S1590-8658(07)00464-1 [pii] 10.1016/j.dld.2007.07.155.

    Article  PubMed  CAS  Google Scholar 

  42. Hamilton SR. Colorectal carcinoma in patients with Crohn’s disease. Gastroenterology. 1985;89(2):398–407. doi:S001650858500227X [pii].

    PubMed  CAS  Google Scholar 

  43. Winkler R, Wittmer A, Heusermann U. Cancer and Crohn’s disease. Z Gastroenterol. 2002;40(8):569–76. doi:10.1055/s-2002-33417.

    Article  PubMed  CAS  Google Scholar 

  44. Lad SV, Haider MA, Brown CJ, McLeod RS. MRI appearance of perianal carcinoma in Crohn’s disease. J Magn Reson Imaging. 2007;26(6):1659–62. doi:10.1002/jmri.21186.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tanya Chawla MBBS, MRCP, FRCP, FRCPC .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Rogalla, P., Chawla, T. (2012). MRI in Inflammatory Bowel Disease. In: Baumgart, D. (eds) Crohn's Disease and Ulcerative Colitis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0998-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-0998-4_18

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-0997-7

  • Online ISBN: 978-1-4614-0998-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics